College of Pharmacy Research
September 3, 2020
UAMS Researchers Awarded $11.4 Million Grant to Continue Study of Cancer Therapy Side Effects
LITTLE ROCK — Led by Marjan Boerma, Ph.D., a team of University of Arkansas for Medical Sciences (UAMS) researchers has received a five-year $11.4 million grant to continue research into the side effects of cancer therapies, including radiation and chemotherapies. The Centers for Biomedical Research Excellence (COBRE), a program of the National Institute of General…
June 10, 2020
UAMS-UA Research Yields Long-lasting Disinfectant Spray for Surfaces
Researchers at UAMS and University of Arkansas, Fayetteville, are developing a long-lasting spray that coats and disinfects surfaces for extended periods, even in heavy use, and is less likely to transmit infectious diseases. The project is one of many at both campuses that uses research funding quickly made available during the COVID-19 pandemic for projects…
January 27, 2020
Bone Research Showcased as Vibrant, Vital at UAMS
Bone health is an expanding area of research with far-reaching clinical applications — from regenerating limbs to stopping bone cancer in its tracks — and UAMS is well-situated as a leader in the field. That was the resounding theme of the Showcase of Medical Discoveries: A Focus on Bone Research, held Jan. 22 at UAMS….
April 17, 2018
UAMS Fights Opioid Epidemic on All Fronts
April 17, 2018 | The University of Arkansas for Medical Sciences (UAMS) is attacking the nationwide opioid epidemic on multiple fronts that have produced new research and treatment options for patients and health care providers across Arkansas and beyond. “As the state’s only health sciences university, UAMS is uniquely positioned to address this issue head on…
August 16, 2017
UAMS Study Finds Day-Supply of Prescribed Opioids Most Decisive Factor in Likelihood of Long-Term Use
Aug. 16, 2017 | The single biggest factor determining whether a patient is likely to use opioids long term may be the number of days’ supply initially prescribed, according to a study by UAMS researchers. “Compared to someone prescribed two days versus seven days, that person with a seven-day supply is twice as likely to…
July 31, 2017
UAMS Researchers Receive $2.9 Million Grant to Study Possible Treatment for Radiation Injury
July 31, 2017 | A team of University of Arkansas for Medical Sciences (UAMS) research scientists recently was awarded a $2.97 million, five-year grant by the National Institute of Allergy & Infectious Diseases to investigate a possible treatment for the long-term health effects from injury caused by exposure to high levels of radiation. Marjan Boerma,…
June 28, 2016
UAMS Receives NIH Grant for First Comprehensive Study of Synthetic Marijuana Dangers
LITTLE ROCK — A team of University of Arkansas for Medical Sciences (UAMS) researchers has received a federal grant to conduct the first comprehensive study of the dangers posed by synthetic marijuana products. The $2.7 million grant from the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) will enable a seven-member interdisciplinary…
Previous page